Table 3 Comparison of baseline characteristics between ticagrelor discontinued and ticagrelor continued arms.
S. no. | Outcomes | Ticagrelor discontinued (237) | Ticagrelor continued (72) | p value |
|---|---|---|---|---|
1 | Composite outcome(n,%) | 11 (4.6%) | 6 (8.3) | 0.23 |
2 | Death | 0 | 0 | NA |
3 | Recurrent MI | 3 (1.3%) | 1 (1.4%) | 0.94 |
4 | Re-intervention | 3 (1.2%) | 0 | 0.34 |
5 | Major bleeding | 7 (3%) | 5 (6.9) | 0.12 |